MedTrace Logo

Safety Study for An Artificial Disc Nucleus Replacement to Treat Chronic Low Back Pain

NCT04004156 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2025-05-21

No results posted yet for this study

Summary

This study will be a prospective, open-label, multi-center study that will collect safety data for the minimally invasive PerQdisc Nucleus Replacement Device deployed to reduce chronic low back pain.

Conditions

  • Degenerative Disc Disease
  • Chronic Low-back Pain

Interventions

DEVICE

PerQdisc® Nucleus Replacement Device.

All patients that meet the inclusion/exclusion criteria will receive the PerQdisc® Nucleus Replacement Device.

Sponsors & Collaborators

  • Spinal Stabilization Technologies

    lead INDUSTRY

Principal Investigators

  • Michael Hess, MD · London Spine Clinic/ATOS-Klinik

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2022-03-17
Completion
2023-01-23

Countries

  • Belgium
  • Canada
  • Croatia
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04004156 on ClinicalTrials.gov